NCT07333222Recruiting
Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
Prospective, Placebo-controlled Study on the Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
* Objective assessment of clinical symptoms resulting from stroke, as well as changes in mobility and quality of life, and determination of changes resulting from therapies * Objective assessment of the quality of life, functionality, and clinical symptoms of patients with multiple sclerosis (MS) and determination of changes resulting from therapies * Comparison of measured data from the two main neurological patient groups (stroke, multiple sclerosis) and follow-up of changes in relation to themselves and each other. * Mapping the role of the placebo effect in neuromodulation devices by comparing subjective and objective outcomes. * Analyzing the expectations and experiences of patients receiving placebo treatment using quality of life questionnaires. * Analyzing the effects of the Mollii suit among subgroups of MS and stroke patients. * Assessing the safety, possible side effects, and tolerability of the Mollii suit. * Mapping changes in gait pattern due to the effects of therapy using 3D motion analysis. * Examining the maintenance effects of neuromodulation during a 1-month follow-up.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 19 Dec 2025
- Start date
- 12 Jan 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Somogy Megyei Kaposi Mór Teaching Hospital
- Diseases
- Stroke, Multiple sclerosis
- NCT number
- NCT07333222
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 12 Jan 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- irregular medication use
- drug use
- current participation in individual or group exercise program outside of standard physical therapy
Other illness
- severe heart disease
- seizure disorder
- untreated diabetes
- severe visual or hearing impairment
- other neurological conditions affecting motor function
- smoking after diagnosis of stroke
Other
- multiple strokes in medical history
- systolic blood pressure less than 120 or higher than 160 mmHg
- orthostatic hypotension
- arotid artery stenosis
- hemophilia
- traumatic brain injury
- abnormal electroencephalography
- abnormal blood panel
- use of sedatives
- severe aphasia (Western Aphasia Battery ≤ 25)
- severe sensory dysfunction
- severe orthopedic problems
- alcoholism
- unable to walk at least 10 m with or without assistance in 6 minutes
- BBS score ≤ 32
- BI score ≤ 70
Who the study is looking for
- suffered a first ischemic stroke, diagnosed by a neurologist based on CT or MR imaging
- neurological examination revealed mobility and postural limitations
- confirmed multiple sclerosis diagnosed by a neurologist based on MRI imaging
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Somogy County Kaposi Mór Teaching Hospital Coordinator of this site? Confirm its status | Kaposvár | Hungary | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.